contents

business
 
editorial
news
press room
press service
information
trade fairs
classifieds
useful links

Jacobs receives contract from Genentech

Jacobs Engineering Group Inc. announced that they are providing engineering and construction services for Genentech Inc.'s new manufacturing facility to be located in Tuas, Singapore. The new facility is intended for the manufacture of bulk LUCENTIS (ranibizumab injection), a treatment for wet age-related macular degeneration. Working in partnership with Bovis Lend Lease in Singapore, Jacobs will provide full engineering services, including modular design and fabrication from their Charleston, S.C., modular fabrication operations.



write your comments about the article :: © 2007 Construction News :: home page